Results 21 to 30 of about 775,077 (341)
Functional Genomics for the Identification of Modulators of Platelet-Dependent Thrombus Formation
Despite the absence of the genome in platelets, transcription profiling provides important insights into platelet function and can help clarify abnormalities in platelet disorders.
Elien Vermeersch+6 more
doaj +1 more source
Factor V Leiden and thrombosis in patients with systemic lupus erythematosus: a meta-analysis. [PDF]
The aim of this study was to perform a meta-analysis of the association between the factor V Leiden polymorphism (FVL) and thrombosis among patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibody (aPL) positivity.
Barton, JL+6 more
core +2 more sources
Introduction: Bovine and ovine mucosa represent alternate anticoagulants to porcine mucosa for production of unfractionated heparin (UFH). Standardized heparins from various sources can be blended and potency adjusted, blended heparins exhibit comparable
Guy Olson BS+8 more
doaj +1 more source
Hepatic artery thrombosis after liver transplantation: Radiologic evaluation [PDF]
Hepatic artery thrombosis after liver transplantation is a devastating event requiring emergency retransplantation in most patients. Early clinical signs are often nonspecific.
Bowen, A+6 more
core +1 more source
Introduction Patients with mild to moderate bleeding symptoms referred for coagulation investigation sometimes never receive a definitive diagnosis. Bleed assessment tools have been developed and validated to assess the severity of symptoms.
Elena Holm+3 more
doaj +1 more source
Vascular complications after liver transplantation: A 5-year experience [PDF]
During the past 5 years, 104 angiographic studies were performed in 87 patients (45 children and 42 adults) with 92 transplanted livers for evaluation of possible vascular complications. Seventy percent of the studies were abnormal.
Bron, KM+4 more
core +1 more source
Patients with a second venous thromboembolism generally receive anticoagulant treatment indefinitely, although it is known that the recurrence risk diminishes over time while the risk of hemorrhage persists with continued anticoagulation and increases ...
Tom van der Hulle+7 more
doaj +1 more source
Background Emicizumab, a bispecific antibody factor VIII mimetic, is approved for prophylaxis in hemophilia, and has different risks and side effects compared to factor VIII products.
Beth Boulden Warren+9 more
doaj +1 more source
Mathematical modeling of thrombus formation in idealized models of aortic dissection: Initial findings and potential applications [PDF]
Aortic dissection is a major aortic catastrophe with a high morbidity and mortality risk caused by the formation of a tear in the aortic wall. The development of a second blood filled region defined as the “false lumen” causes highly disturbed flow ...
Menichini, C, Xu, XY
core +1 more source
Hypercoagulability and Thrombosis
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License [...]
M.D. Cappellini, E. Poggiali
openaire +5 more sources